Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs

Tuberculosis (TB) is still the number one cause of death due to an infectious disease. Pharmacokinetics and pharmacodynamics of anti-TB drugs are key in the optimization of TB treatment and help to prevent slow response to treatment, acquired drug resistance, and adverse drug effects. The aim of thi...

詳細記述

保存先:
書誌詳細
出版年:Clin Pharmacokinet
主要な著者: Sturkenboom, Marieke G. G., Märtson, Anne-Grete, Svensson, Elin M., Sloan, Derek J., Dooley, Kelly E., van den Elsen, Simone H. J., Denti, Paolo, Peloquin, Charles A., Aarnoutse, Rob E., Alffenaar, Jan-Willem C.
フォーマット: Artigo
言語:Inglês
出版事項: Springer International Publishing 2021
主題:
Review Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7935699/
https://ncbi.nlm.nih.gov/pubmed/33674941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-021-00997-0
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料